Overview

Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
Assessment of safety and efficacy of voriconazole in real-life setting in the treatment of high risk patients with invasive fungal infections. The study is conducted in Slovakia only.
Details
Lead Sponsor:
Pfizer
Treatments:
Voriconazole